| | | |   | | | | By Adam Feuerstein Adobe Eisai's Alzheimer's drug, Leqembi, has limitations but is groundbreaking in a field that hasn't seen real medical progress in decades. Read More | | By Nicholas Florko Greg Nash/AP Lawmakers, state legislators, and regulators are pushing prisons to explain their hepatitis C treatment rates after a STAT investigation. Read More | | By Ed Silverman Alex Hogan/STAT From new hires to departures, promotions, and transfers, here are the latest comings and goings in the pharmaceutical industry. Read More | | Sponsored Insight by BIOTECH SHOWCASE™ Discover cutting-edge technologies and the latest innovations at Biotech Showcase Biotech Showcase, taking place January 9-11, 2023, will feature 400 presenting companies. Ranging from publicly traded companies to seed-stage biotechs, presenting companies will showcase the latest innovations available for investment and licensing opportunities. Take advantage of this opportunity to meet one-to-one with the most innovative companies in the biopharma sector. Don't delay! There is still time to register. Secure your spot today. | | By Jonathan Wosen Adobe The San Diego-based biotech announced Thursday that the termination of its deal with Janssen will result in layoffs and curtailed drug development. Read More | |
No comments